A Japanese pharmaceutical company focused on developing and commercializing innovative treatments for central nervous system disorders, oncology, and cardiovascular diseases. Investors track Otsuka for its strong R&D pipeline and global partnerships, including its stake in Otsuka Pharmaceutical and collaboration with U.S.-based Otsuka America Pharmaceutical.
4 members of Congress have disclosed 9 trades in Otsuka Holdings Co., Ltd. (OTSKY), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 5 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |
| 2023-03-31 | Daniel Goldman | sell | $1K – $15K |
| 2023-02-27 | Daniel Goldman | buy | $1K – $15K |
| 2018-07-17 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2018-01-19 | Thomas MacArthur | buy | $15K – $50K |
| 2017-12-19 | Thomas MacArthur | sell | $15K – $50K |
| 2017-01-10 | Thomas MacArthur | buy | $15K – $50K |
| 2017-01-07 | Kurt Schrader | sell | $1K – $15K |
| 2015-12-08 | Kurt Schrader | buy | $1K – $15K |